Sign up for email alerts of latest news, events, new funding opportunities and more.
Showing all Leadership Success Stories
26 Jan 2018
The MRC recognised the lifetime achievements of Professor Janet Darbyshire CBE FMedSci at our Millennium Medal Award Ceremony at the House of Commons on 24 January.
9 Nov 2017
Scientists from the UK-PBC, a MRC Stratified Medicine Initiative, have been instrumental in getting the first new drug in 20 years for a progressive liver disease approved. Obeticholic acid, to treat primary biliary cholangitis (PBC), received FDA approval in 2016 and NICE approval in March 2017.
7 Nov 2017
In February 2016, Dr Kathy Niakan’s team at the Francis Crick Institute became the first to receive permission from the Human Fertilisation and Embryology Authority (HFEA) to use the genome editing technique 'CRISPR-Cas9' in human embryos.
1 Nov 2017
An MRC Newton-funded project has been awarded the Newton Prize worth £200,000 at an event in New Delhi today, for testing the introduction of a new vital sign device into routine maternity care in hospitals in India and Africa.
1 Nov 2017
The ground-breaking results from the PROUD study, published in 2016, indicate that a treatment known as PrEP is highly protective for a high-risk group of people, reducing the risk of infection by 86 per cent. This protection is the highest reported from a randomised controlled trial of PrEP to date
4 Oct 2017
The MRC Laboratory of Molecular Biology is delighted to announce the awarding of the 2017 Nobel Prize in Chemistry to Dr Richard Henderson, jointly with Professor Jacques Dubochet and Dr Joachim Fran.
13 Sep 2017
New scientists will explore ways to tackle antimicrobial resistance through a £2.85m investment in a PhD training programme by the Medical Research Foundation (MRF), the charitable foundation of the MRC.
4 Sep 2017
Fourteen outstanding articles have been shortlisted for this year’s Max Perutz Science Writing Award, the MRC’s annual writing competition.
29 Aug 2017
Two regenerative medicine researchers have been recognised for their collaborative research efforts, receiving Special Merit Prizes from the UK Regenerative Medicine Platform.
21 Aug 2017
The MRC Cognitive Function and Ageing Study (CFAS) has led to important insights into the association of lifestyle factors with the risk of cognitive impairment. In 2015 the findings from this important study helped predict future demand for long term care and likely associated costs, thereby influencing the 2015 NICE Dementia Guidelines.